Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | 240,000 | reported | 02 Jan 2026 | tx 26+1,326,888−140,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 240,000 | 0.00 USD | deriv |
| 01 Jul 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15,000 | 1.50 USD | |
| 01 Jul 2025 | SALE | ARS Pharmaceuticals, Inc. | 15,000 | 16.99 USD | |
| 01 Jul 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 18 Jun 2025 | SALE | ARS Pharmaceuticals, Inc. | 15,000 | 16.00 USD | |
| 18 Jun 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15,000 | 1.50 USD | |
| 18 Jun 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 20 Mar 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 10,000 | 1.50 USD | |
| 20 Mar 2025 | SALE | ARS Pharmaceuticals, Inc. | 10,000 | 14.00 USD | |
| 20 Mar 2025 | EXERCISE | ARS Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 152,300 | 0.00 USD | deriv |
| 04 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 6,283 | 14.00 USD | |
| 04 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 6,283 | 1.50 USD | |
| 02 Dec 2024 | SALE | ARS Pharmaceuticals, Inc. | 3,717 | 14.11 USD | |
| 02 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 3,717 | 1.50 USD | |
| 02 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 3,717 | 0.00 USD | deriv |
| 04 Dec 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 6,283 | 0.00 USD | deriv |
| 18 Sept 2024 | SALE | ARS Pharmaceuticals, Inc. | 10,000 | 14.00 USD | |
| 18 Sept 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10,000 | 1.50 USD | |
| 18 Sept 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 19 Aug 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10,000 | 1.50 USD | |
| 19 Aug 2024 | SALE | ARS Pharmaceuticals, Inc. | 10,000 | 14.00 USD | |
| 19 Aug 2024 | EXERCISE | ARS Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |